Systemic Analysis of Endoscopic Sinus Complications and Assessment of Mental Well-Being

Introduction: Chronic sinusitis is symptomatic inflammation of the nasal cavities and paranasal sinuses lasting more than 12 weeks, 1 with clinical manifestations such as nasal obstruction, rhinorrhea, facial pressure pain, and decreased sense of smell, associated with endoscopic or CT findings of sinusitis. Objective: This study aims to study Systematic analysis of endoscopic sinus complications and assessment of the quality of life. Patients and Methods: In this study, data were collected for this study of patients with endoscopic sinuses, including 70 patients, which were divided into two groups, one of which was the patients’ group (40) and the control group (30). A demographic analysis was conducted for sinus data in different hospitals in Iraq through the SNOT-22 program, where these data included the parameters age, sex, BMI, marital status, economic level, and educational level. An assessment of the quality of life of patients with sinusitis was carried out, which included the parameters related to sinus complications Sleep, Anxiety, Breathing, and Effectiveness, which were analyzed statistically by mean SD. The group of sinus patients was evaluated through SNOT-22 analysis, where the variables cough, breathing, runny nose, sleep, and sneezing were shown, which were designed on sinus patients before surgery and others after surgery, which lasted for six months. Results and Discussion: The patients' group included 9 (22.5%) and the control group 7 (23.3%) with a P-VALUE of 0.048, while the age older than 40 years included the patients' group 12 (30%) and the control group 11 (36.7%). To follow up, this study determined that male and female patients of the patients’ group were more affected and increased than patients of the control group, with a P-value of 0.041. an analysis was conducted for the presence of nasal study, which included asthma, recurring infection, allergies, and immune disorders for both groups, where asthma patients' group 14 (35%) and control group 11 (36.7%) and recurring infection patients' group 8 (20%) and the control group 9 (30%), while the allergies where the patients' group 11 (27.5%) and the control group 6 (20%) with a P-VALUE 0.043. Conclusion: As a result of risk factors, previous symptoms, and SNOT-22 assessment, the patient group is considered to be more at risk for quality of life than the control grou